Biotechnology Assets SA

XMAD:BST (Spain)  
€ 0.33 (+4.33%) Dec 4
At Loss
P/B:
2.80
Market Cap:
€ 20.94M ($ 22.06M)
Enterprise V:
€ 22.60M ($ 23.81M)
Volume:
190.76K
Avg Vol (2M):
156.86K
Trade In:
Volume:
190.76K
At Loss

Business Description

Description
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset 0.49
Debt-to-Equity 0.31
Debt-to-EBITDA 8.43
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.3
Distress
Grey
Safe
Beneish M-Score -1.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.56
9-Day RSI 57.04
14-Day RSI 55.76
6-1 Month Momentum % -22.14
12-1 Month Momentum % -35.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.85
Quick Ratio 0.85
Cash Ratio 0.19
Days Sales Outstanding 291.36
Days Payable 856.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8
Shareholder Yield % 11.8

Financials (Next Earnings Date:2025-04-25 Est.)

XMAD:BST's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biotechnology Assets SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 3.055
EPS (TTM) (€) -0.05
Beta 2.08
Volatility % 21.03
14-Day RSI 55.76
14-Day ATR (€) 0.02554
20-Day SMA (€) 0.3131
12-1 Month Momentum % -35.95
52-Week Range (€) 0.236 - 0.458
Shares Outstanding (Mil) 64.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biotechnology Assets SA Filings

Filing Date Document Date Form
No Filing Data

Biotechnology Assets SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Biotechnology Assets SA Frequently Asked Questions

What is Biotechnology Assets SA(XMAD:BST)'s stock price today?
The current price of XMAD:BST is €0.33. The 52 week high of XMAD:BST is €0.46 and 52 week low is €0.24.
When is next earnings date of Biotechnology Assets SA(XMAD:BST)?
The next earnings date of Biotechnology Assets SA(XMAD:BST) is 2025-04-25 Est..
Does Biotechnology Assets SA(XMAD:BST) pay dividends? If so, how much?
Biotechnology Assets SA(XMAD:BST) does not pay dividend.

Press Release

Subject Date
No Press Release